HDAC9 and glomerulosclerosis: Additional studies also revealed that the silencing of histone deacetylase 9 (HDAC9) mitigated glomerulosclerosis, inflammatory cytokine release, podocyte apoptosis, and renal injury, all of which were achieved through the JAK2/STAT3 pathway [177].